‘This case is about the color purple’: GSK’s suit against Sandoz refuted

By Ben Hargreaves contact

- Last updated on GMT

(Image: Getty/LightFieldStudios)
(Image: Getty/LightFieldStudios)

Related tags: Gsk, Sandoz, Vectura, Asthma, Copd

England’s High Court throws out the claim that Sandoz’s inhaler product passed off the appearance of GSK’s rival through its use of the color purple in packaging.

The case relates to GSK’s Seretide Accuhaler (salmeterol and fluticasone) and Seretide Evohaler, Sandoz’s AirFluSal Forspiro, which was licensed from Vectura.

GSK had suggested in its case that the rival product had ‘passed off’ as being connected to, and/or equivalent to, its own product through its ‘get up and packaging’.

Legal proceedings were presided over by, Richard Arnold, who observed​ in his introduction that “this case is about the color purple”​, and that GSK’s case “relied upon the use of purple”​ by the end of the trial.

Both GSK and Sandoz’s products use the color purple in their packaging. Sandoz product was released onto the market as a generic version of GSK’s in 2015, with the original product having been on the market since 1999.

The case against Sandoz and the three other co-defendants, including Aeropharm and Hexal, reached trial after nearly four years and found in favor of the defendants, after the judge concluded that Aeropharm and Hexal could not be found jointly liable.

A spokesperson for Sandoz told us that the decision allows Sando to continue to market its inhaler in the UK.

Tim de Gavre, country head for Sandoz UK, said, “This is a welcome decision that secures access for the NHS and its patients to appropriate medicines that help save money and drive long-term sustainability.”

Sandoz’s product, originally developed by Vectura, is a dry powder inhaler indicated for the treatment of asthma and chronic obstructive pulmonary disease.

Related news

Show more

Related products

show more

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Lactium, your ally to manage day to day stress

Lactium, your ally to manage day to day stress

Ingredia | 27-Aug-2020 | Product Presentation

Stress has been called the ‘health epidemic of the 21st century’ by the World Health Organization. Increasingly, consumers are looking for safe, reliable...

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Follow us


View more